Search
Search Results
##search.searchResults.foundPlural##
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4696PDF: 1705HTML: 2685Untitled: 188 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3970PDF: 1103HTML: 1914Fig.1: 203Fig. 2: 101Table 1: 183Table2: 198Table 3: 179 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1640PDF: 777HTML: 921cover letter: 246 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1218HTML: 281PDF: 892Suppl. Files: 431 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1218PDF: 737HTML: 4341Figure 1: 139Untitled: 107Untitled: 151 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1476PDF: 559HTML: 169 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
737PDF: 876Suppl. Files: 112HTML: 61 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7802PDF: 3166HTML: 1170 -
-
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1247PDF: 746HTML: 294 -
-
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
998PDF: 729HTML: 268 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1195PDF: 870HTML: 277 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2849PDF: 661HTML: 1918figure 1: 145figure 2: 159 -
-
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3168PDF: 1483HTML: 392 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1957PDF: 763HTML: 1024 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1018PDF: 524HTML: 1671Figures: 143Fifures Sanz: 156tables Sanz: 163Untitled: 155 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4123PDF: 1486HTML: 421 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1534PDF: 763HTML: 838jdoe, table 2 infections CML .doc: 171jdoe, table 1 infections CML .doc: 160 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1719PDF: 1010HTML: 214 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2166PDF: 1002HTML: 1971Characteristic of study group: 175 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2690PDF: 1067HTML: 3252 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
776PDF: 772HTML: 95 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3511PDF: 1077HTML: 23314 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3300PDF: 1253HTML: 1845Fig.1: 179Fig. 2: 186 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1290PDF: 809HTML: 10018cover letter to the editor: 146tile page: 234 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3199PDF: 1307HTML: 2604







